Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel
- Status
- TERMINATED
- Phase
- PHASE2
Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Intensified Chemotherapy in CRC After Resection of Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
XELOX for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV
- Status
- COMPLETED
- Phase
- PHASE2
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
- Status
- COMPLETED
- Phase
- N/A
Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE2
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings
- Status
- COMPLETED
- Phase
- PHASE4